Contrast-induced nephropathy in critical care

Critical Care Nurse

Volumn 32, Issue 6, 2012, Pages 15-24

  Wood, Stephen P ^a  

^a Harvard Affiliated Emergency Medicine Residency Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT;

ACUTE KIDNEY FAILURE; ARTICLE; CHEMICALLY INDUCED DISORDER; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; IATROGENIC DISEASE; INTENSIVE CARE; KIDNEY FUNCTION TEST; MALE; MEDICAL EDUCATION; METHODOLOGY; MORTALITY; PROGNOSIS; RADIOGRAPHY; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE;

ACUTE KIDNEY INJURY; CONTRAST MEDIA; CRITICAL CARE; EDUCATION, MEDICAL, CONTINUING; FEMALE; HUMANS; IATROGENIC DISEASE; KIDNEY FUNCTION TESTS; MALE; PROGNOSIS; RENAL DIALYSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84873435493     PISSN: 02795442     EISSN: 19408250     Source Type: Journal    
DOI: 10.4037/ccn2012465     Document Type: Article

References (49)

1. Weisbord SD. Iodinated contrast media and the kidney. Rev Cardiovasc Med. 2008; 9(suppl 1):S14-S23.
2. McCullough PA. Acute kidney injury with iodinated contrast. Crit Care Med. 2008; 36(4 suppl):S204-S211.
3. Singh J, Daftary A. Iodinated contrast media and their adverse reactions. J Nucl Med Technol. 2008;36(2):69-74.
4. Reddan D, Laville M, Garovic VD. Contrastinduced nephropathy and its prevention: what do we really know from evidence-based findings? J Nephrol. 2009;22(3):333-351.
5. Weisbord SD, Palevsky PM. Radiocontrastinduced acute renal failure. J Intensive Care Med. 2005;20(2):63-75.
6. Shema L, Ore L, Geron R, Kristal B. Contrastinduced nephropathy among Israeli hospitalized patients: incidence, risk factors, length of stay and mortality. Isr Med Assoc J. 2009;11(8):460-464.
7. Weisbord S, Mor M, Resnick A, et al. Incidence and outcomes of contrast-induced AKI following computed tomography. Clin J Am Soc Nephrol. 2008;3(5):1274-1281.
8. Rashid A, Brieva J, Stokes B. Incidence of contrast-induced nephropathy in intensive care patients undergoing computerised tomography and prevalence of risk factors. Anaesth Intensive Care. 2009;37(6):968-975.
9. Mehran R, Nikolsky E, Kirtane AJ, et al. Ionic low-osmolar versus nonionic isoosmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study. JACC Cardiovasc Interv. 2009;2(5):415-421.
10. Aspelin P, Aubry P, Fransson SG, et al; Nephrotoxicity in High-Risk Patients Study of Iso-Osmolar and Low-Osmolar Non-Ionic Contrast Media Study Investigators. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med. 2003;348(6):491-499.
11. Bartels E, Brun G, Gammeltoft A, Gjorup P. Acute anuria following intravenous pyelography in a patient with myelomatosis. Acta Med Scand. 1954;150(4):297-302.
12. Seeley R, Stephens T, Tate P. Cardiovascular system: blood. In: Anatomy and Physiology. Boston, MA: Times Mirror/Mosby College Publishing; 1989:chap 19.
13. Eisenberg R, Johnson N. Specialized imaging techniques. In: Comprehensive Radiographic Pathology. 4th ed. St Louis, MO: Mosby Elsevier Publishing; 2007:chap 2.
14. Hong S, Cochran S. Immediate hypersensitivity reactions to radiocontrast media: clinical manifestations, diagnosis, and treatment. Up-to-Date Web site. http://www.uptodate.com/contents/immediate-hypersensitivity-reactions-to-radiocontrast-media-clinical-manifestations-diagnosis-and-treatment?source=search_result&search=immediate+hypersensitivity+reactions+to+radiocontrast+media&selectedTitle=1%7E150.Updated June 8, 2012. Accessed August 25, 2012.
15. Tramèr MR, von Elm E, Loubeyre P, Hauser C. Pharmacological prevention of serious anaphylactic reactions due to iodinated contrast media: systematic review. BMJ. 2006; 333(7570):675.
16. Nayak K, White A, Cavendish J, Barker C, Kandzari D. Anaphylactoid reactions to radiocontrast agents: prevention and treatment in the cardiac catheterization laboratory. J Invasive Cardiol. 2009;21(10):548-551.
17. Canter M. Anaphylactoid reactions to radiocontrast media. Allergy Asthma Proc. 2005: 26(3);199-203.
18. Beaty A, Lieberman P, Slavin R. Seafood allergy and radiocontrast media: are physicians propagating a myth? Am J Med. 2008; 121(2):158.e1-4.
19. Huang S. Seafood and iodine: an analysis of a medical myth. Allergy Asthma Proc. 2005; 26(6):468-469.
20. Wang C, Cohan R, Ellis J, Adusumilli S, Dunnick N. Frequency, management, and outcome of extravasation of nonionic iodinated contrast medium in 69 657 intravenous injections. Radiology. 2007;243(1):80-87.
21. Bellin M, Jakobsen J, Tomassin I, et al. Contrast medium extravasation injury: guidelines for prevention and management. Eur Radiol. 2002;12(11):2807-2812.
22. Bahrami S, Raman S, Saulk S, et al. Ten-year experience with nephrogenic systemic fibrosis: case-control analysis of risk factors. J Comput Assist Tomogr. 2009;33(6):819-823.
23. Kallen A, Jhung M, Cheng S, et al. Gadolinium-containing magnetic resonance imaging contrast and nephrogenic systemic fibrosis: a case-control study. Am J Kidney Dis. 2008; 51(6):966-975.
24. Jabara R, Gadesam RR, Pendyala LK, et al. Impact of the definition utilized on the rate of contrast-induced nephropathy in percutaneous coronary intervention. Am J Cardiol. 2009;103(12):1657-1662.
25. McCullough P, Wolyn R, Rocher L, Levin R, O'Neill W. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med. 1997; 103:368-375.
26. Rihal C, Textor S, Grill D, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002;105:2259-2264.
27. Rudnick M, Feldman H. Contrast-induced nephropathy: what are the true clinical consequences? Clin J Am Soc Nephrol. 2008;3: 263-272.
28. Zoungas S, Ninomiya T, Huxley R, et al. Systematic review: sodium bicarbonate treatment regimens for the prevention of contrastinduced nephropathy. Ann Intern Med. 2009; 151(9):631-638.
29. Abu Jawdeh BG, Kanso AA, Schelling JR. Evidence-based approach for prevention of radiocontrast-induced nephropathy. J Hosp Med. 2009;4(8):500-506.
30. Rudnick M, Goldfarb S, Wexler L, et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. Kidney Int. 1995;47(1):254-261.
31. Parfrey P, Griffiths S, Barrett B, et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both: a prospective controlled study. N Engl J Med. 1989;320(3):143-149
32. Barrett B, Parfrey P, Vavasour H, et al. Contrast nephropathy in patients with impaired renal function: high versus low osmolar media. Kidney Int. 1992;41(5):1274-1279.
33. Cigarroa R, Lange R, Williams R, Hillis L. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med. 1989;86(6 pt 1):649-652.
34. Toprak O. Conflicting and new risk factors for contrast induced nephropathy. J Urol. 2007;178(6):2277-2283.
35. Nunag M, Brogan M, Garrick R. Mitigating contrast-induced acute kidney injury associated with cardiac catheterization. Cardiol Rev. 2009;17(6):263-269.
36. Kato K, Sato N, Yamamoto T, et al. Valuable markers for contrast-induced nephropathy in patients undergoing cardiac catheterization. Circ J. 2008;72(9):1499-1505.
37. McCullough P, Adam A, Becker C, et al; CIN Consensus Working Panel. Risk prediction of contrast-induced nephropathy. Am J Cardiol. 2006;98(6A):27K-36K.
38. Madsen T, Pearson R, Muhlestein J, et al; Intermountain Heart Collaborative (IHC) Study Group. Risk of nephropathy is not increased by the administration of larger volume of contrast during coronary angiography. Crit Pathw Cardiol. 2009;8(4):167-171.
39. Rudnick M, Tumlin J. Pathogenesis, clinical features, and diagnosis of contrast-induced nephropathy. Up-to-Date Web site. http://www.uptodate.com/online/content/topic.do?topicKey=renlfail/9576&selectedTitle=1%7E40&source=search_result#. Updated February 17, 2012. Accessed August 25, 2012.
40. Ellis J, Cohan R. Prevention of contrastinduced nephropathy: an overview. Radiol Clin North Am. 2009;47(5):801-811.
41. Vallon V, Mühlbauer B, Osswald H. Adenosine and kidney function. Physiol Rev. 2006; 86(3):901-940.
42. Persson P, Hansell P, Liss P. Pathophysiology of contrast medium-induced nephropathy. Kidney Int. 2005;68(1):14-22.
43. Erley CM, Heyne N, Burgert K, Langanke J, Risler T, Osswald H. Prevention of radiocontrast-induced nephropathy by adenosine antagonists in rats with chronic nitric oxide deficiency. J Am Soc Nephrol. 1997; 8(7):1125-1132.
44. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P; Acute Dialysis Quality Initiative workgroup. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8(4): R204-R212.
45. Abujudeh H, Gee M, Kaewla R. In emergency situations, should serum creatinine be checked in all patients before performing second contrast CT examinations within 24 hours? J Am Coll Radiol. 2009;6(4):268-273.
46. Weisberg L, Kurnik P, Kurnik B. Risk of radiocontrast nephropathy in patients with and without diabetes. Kidney Int. 1994;45: 259-265.
47. Trivedi H, Moore H, Nasr S, et al. A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron Clin Pract. 2003;93(1):C29-C34.
48. Tamura A, Goto Y, Miyamoto K, et al. Efficacy of single-bolus administration of sodium bicarbonate to prevent contrast-induced nephropathy in patients with mild renal insufficiency undergoing an elective coronary procedure. Am J Cardiol. 2009;104(7): 921-925.
49. Trivedi H, Daram S, Szabo A, Bartorelli AL, Marenzi G. High-dose N-acetylcysteine for the prevention of contrast-induced nephropathy. Am J Med. 2009;122(9):874.e9-15.